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Background: The purpose of this study was to examine the prevalence of depressive symptoms, diabetes
self-management, and quality of life in people with diabetes and foot ulcers. Ulcer status, mortality and
amputations were also assessed at six months follow-up.
Methods: This was a cross-sectional survey of people attending outpatient podiatry clinics at a major tertiary
referral hospital. Depressive symptoms were measured using the Patient Health Questionnaire (PHQ). Diabetes
self-care was assessed using the Summary of Diabetes Self Care Activities (SDSCA) measure. Health-related quality
of life was measured using the physical component summary score (PCS) and the mental component summary
score (MCS) of the SF-12.
Results: Of the 60 participants in the study 14 (23.3%) reported mild symptoms of depression (PHQ score 5–9)
and 17 (28.3%) moderate to severe depressive symptoms (PHQ score > 9). Twenty-one (35%) met the criteria for
previously recognized depression (on antidepressants and/or a diagnosis of depression in the last 12 months)
and 17 (28.3%) for depression not previously recognized (PHQ > 4). Seventeen (28%) participants had been
receiving antidepressant treatment for a median duration of 104 weeks (IQR 20, 494 weeks). Despite antidepressant
treatment 12 participants (70.6% of those taking antidepressants) still reported moderate to severe depressive
symptoms at the time of the study. Patients with PHQ scores > 4 reported poorer adherence to diabetes self-care
activities including general diet, exercise, blood sugar monitoring and foot care when compared to those participants
with PHQ scores < 5. No association was found between physical functioning (PCS) and depressive symptoms. Decreasing
mental wellbeing (MCS) was associated with increasing depressive symptoms. At six months follow-up, there were three
deaths and three amputations in participants with PHQ scores > 4 compared with no deaths and 2 amputations
in participants with PHQ scores < 5. There was no association between depressive symptoms and ulcer healing or
ulcer recurrence at the six-month follow-up.
Conclusions: This study found a high prevalence of depressive symptoms both recognized and unrecognized
in people with diabetes and foot ulcers. Depressive symptoms were associated with overall poorer diabetes
self-management and health-related quality of life (HRQoL). There was no association between depressive
symptoms and ulcer outcomes at six-months follow-up.
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Diabetic foot ulcers are one of the most common and
costly complications of diabetes occurring in between 15
and 25% of people with diabetes [1]. They are associated
with considerable deterioration in quality of life and
physical disability [2]. Only two-thirds of ulcers on average
will heal within a median time of six months and recur-
rence of foot ulcers within twelve months is common, oc-
curring in approximately 60% of people [3]. Amputations
are also common following deterioration of the ulcer to
severe infection or gangrene. Mortality following amputa-
tion is high ranging from 39 to 80% at 5 years [4]. Further-
more, once amputated, within 3 years 30-50% of these
people undergo amputation of the contralateral-leg [5].
These figures highlight what a serious public health prob-
lem this is currently and likely to be in the future given
the predicted escalating prevalence of diabetes.
While advances in the treatments of wounds and
knowledge about risk factors such as duration of dia-
betes, persistent hyperglycemia and peripheral neur-
opathy have assisted in the treatment of these patients
[6], significantly less attention has been given to ad-
dressing the psychosocial risk factors contributing to
diabetic complications and more specifically foot ulcers.
It is now well established in the literature that there are
higher than normal rates of depression in people with
diabetes [7] and that comorbid depression contributes
to an increased risk of diabetic complications and mor-
tality [8].
Studies specifically examining the impact of comorbid
depression on the incidence and progression of foot ul-
cers have found depression to be associated with delays
in healing [3] and a threefold increased risk of mortality
within 18 months of presenting with a first foot ulcer
[9]. While depression is likely to occur in response to
foot ulceration [10] it is also associated with a 2 fold in-
creased risk of developing foot ulcers when compared to
people with diabetes and no depression [11].
The significant burden that comorbid depression con-
tributes to people with diabetes is in part due to the fact
that depression is only recognized and appropriately
treated in fewer than 25% of people with diabetes [12].
This paper presents the results of a study of patients with
diabetes attending outpatient podiatry clinics for the treat-
ment of foot ulcers. Its specific aims were to i) examine the
prevalence of depression including previously unrecognized
depression, and ii) determine the effect of depression on
diabetes-self management, health-related quality of life
(HRQoL) and ulcer status at six months follow-up.
Methods
Participants consisted of 60 people with diabetes and
one or more foot ulcers being treated at the foot ulcer
clinics run by the Department of Podiatry at the RoyalHobart Hospital in Tasmania, Australia. Both men and
women aged 18 years and over who had diabetes (type 1
and 2) were eligible. Participants were excluded if they
had a physical or mental condition that prevented them
from signing the consent form or filling in the question-
naires. Participants were approached while waiting to be
seen by the podiatrist at the clinic. Willing participants
could complete the questionnaires while they were wait-
ing for their appointment or they could take them home,
complete them and return them in a prepaid envelope.
This pilot study was approved by the Tasmanian Health
and Medical Human Research Ethics Committee (protocol
H11941). During the recruitment period from February to
August of 2012, 146 people had scheduled outpatient ap-
pointments. Of these patients 75 were excluded and
deemed ineligible due to the following reasons; being non-
diabetic, having an existing mental health problem, their
ulcer had healed or they were being treated for Charcot’s
foot, they failed to show up or were unable to sign the
consent form. Five refused and 11 failed to return their
questionnaires leaving 60 participants in the final analysis
of the study.
Measures
Information from the clinical records included diabetes
type, duration, diabetes-related complications, comor-
bidities, medications including the use of antidepres-
sants. Information about the HbA1C was obtained from
the medical records but due to missing data was only
available for 41 participants. Data on ulcers was also col-
lected from the patients records. As some patients had
more than one ulcer the largest ulcer was classified as
the primary ulcer. Severity of the ulcer was classified ac-
cording to the Texas wound classification scheme and is
based on depth, presence of infection and ischemia [13].
Depressive symptoms were assessed using the 9-item
Patient Health Questionnaire (PHQ-9). The PHQ is a
self-report measure that provides both a diagnosis of
major depressive syndrome and a continuous severity
score, and is based on the American Psychiatric Associa-
tion’s DSM-IV criteria for depressive episodes. Partici-
pants rate how often in the previous two weeks they
have experienced depressive feelings or thoughts. The
scale ranges from 0 (not at all) to 3 (nearly every day).
Total scores range from 0–27. Validation studies have
shown excellent agreement between the self-report PHQ
and a clinician-structured interview in general medical
outpatients and among people with diabetes. Scores
greater than 7 have a sensitivty at 91.9% and specificity
of 59.4% [14]. Participants were classified as having mild
depressive symptoms if they had a PHQ-9 score from 5–
9 and moderate to severe depressive symptoms in the
those who scored greater than 9 on the PHQ. Patients
categorized as having previously recognized depression
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pressants for depression and/or those who answered yes
to the following question, “over the past 12 months have
you been diagnosed by a doctor or other health care pro-
fessional with depression”. Unrecognized depression in-
cluded those participants who did not meet the criteria
for recognized depression but had a PHQ score greater
than 4 (inclusive of mild, moderate and severe symptoms).
Diabetes self-care was assessed using the Summary of
Diabetes Self Care Activities (SDSCA) measure. Partic-
pants were required to indicate on how many of the last
seven days they attended to self care activities in the
areas of general diet, specific diet (fat intake), exercise,
blood glucose testing and foot care. Scores range from
0–7 with higher scores indicative of more attention to
self management activities. This questionnaire has been
shown to be a valid and reliable measure of diabetes
self-management in multiple trials with good internal
consistency, (mean correlation = 0.47) and acceptable val-
idity (mean correlation = 0.23) [15].
The Medical Outcome Study Short-Form-12 (SF-12)
was used to assess HRQoL. It measures physical and
mental health by means of two summary scores: a phys-
ical component summary (PCS) and mental component
summary (MCS) [16]. Both scores range between 0 and
100, with a higher score indicating better health. The
SF-12 shows acceptable validity in predicting overall
quality of life in people with foot ulcers in terms of
physical functioning (r2 = 0.26) and mental functioning
(r2 = 0.372) [17].
Statistical analysis
Basic despriptive statistics are presented including per-
centages, means and standard deviations. Group differ-
ences were examined using chi-square tests for categorical
variables. Fishers exact test was applied where 20% of cell
frequencies fell below five. Independent samples t-tests
and one-way analysis of variance were used for compari-
son of continuous normally distributed variables and the
Kruskal-Wallis test for continuous non-normally distrib-
uted variables.
Results
Table 1 shows the characteristics of participants by PHQ
category. The majority of participants were men, retired
and receiving a pension, had three or more diabetes re-
lated complications in addition to the comorbidities of
hypertension and hyperlipidemia. The majority of pri-
mary ulcers were superficial and neuroischaemic. Nine
(15%) participants had an HbA1c within the recommended
guidelines. Of the 60 participants in the study 31 (51.7%)
reported having depressive symptoms (PHQ> 4). Of those
31 participants, 14 (23.3% of total sample) could be further
classified and having mild depression (PHQ 5–9) and 17(28.3%) as moderate to severe depression (PHQ > 9).
There were no significant differences between the
groups except with current use of antidepressants.
Seventeen (28.3%) participants were currently taking anti-
depressants for depression and a greater proportion of
them reported moderate to severe depressive symptoms.
Of the seventeen participants who were on antidepres-
sants for depression there was available data on the dur-
ation of antidepressant treatment for thirteen. The
duration of antidepressant treatment was a median of
104 weeks (IQR 20 and 494 weeks). Of these partici-
pants 6 (46.2%) had been on antidepressants for more
than two years and 3 (23.1%) for more than 10 years.
Table 2 shows mean scores on the SDSCA and the SF-
12 by PHQ category. This SDSCA data was skewed and
therefore analyzed using nonparametric methods. Partic-
ipants with no depressive symptoms (PHQ < 5) reported
higher scores on all domains of the SDSCA except spe-
cific diet. Significant differences between the groups on
specific diet occurred between participants with PHQ
scores < 5 (no depressive symptoms) and those with mild
depressive symptoms PHQ 5–9), p = 0.021 and between
those with mild depressive symptoms and moderate to
severe symptoms (PHQ > 9), p = 0.036. Differences be-
tween the groups on general diet were approaching sig-
nificance (p = 0.06), all other comparisons between the
three groups were not significant. Scores on the SF12
were normally distributed. Scores on physical function-
ing (PCS) were not significantly different between the
groups. This analysis was adjusted for age as this was
strongly associated with measures of physical function-
ing (r = −0.370, p = 0.004). There was a significant differ-
ence between the groups in mental functioning (MCS)
following adjustment for age also (r = 0.374, p = 0.004).
Post-hoc comparisons using the Sheffe test found these
differences to be significant between participants with
PHQ scores < 5 (no depressive symptoms) and those
with mild depressive symptoms PHQ 5–9), p = 0.001
and between those with mild depressive symptoms and
moderate to severe symptoms (PHQ > 9), p = 0.001.
Twenty-one participants (35%) met the criteria for prior
recognition of depression and 17 (28.3%) for depression
not previously recognized. There were no significant dif-
ferences between these two groups on any demographic
or clinical variables. Table 3 shows the break down of de-
pressive symptoms as reported on the PHQ according to
these two groups. Significantly more participants with
previously unrecognized depression reported depressive
symptoms in the mild category compared to people with
recognized depression. Whereas a greater proportion of
participants with recognized depression reported moder-
ate to severe depressive symptoms compared to those
with unrecognized depression. Chi-square analysis showed
these groups to be significantly different at P ≤ 0.0001.
Table 2 Diabetes self management and quality of life in participants according to PHQ score
No depressive
symptoms PHQ < 5
Mild depressive
symptoms (PHQ 5–9)
Moderate to severe depressive
symptoms (PHQ > 9)
P value
Mean (± sd) Mean (± sd) Mean (± sd)
SDSCA scores
General diet 5.9 (1.9) 5.4 (2.2) 4.3 (2.4) 0.06
Specific diet 4.2 (1.3) 5.3 (1.5) 3.8 (2.2) 0.04
Exercise 1.8 (2.1) 0.9 (1.3) 1.1 (2.0) 0.19
Blood sugar monitoring 5.7 (2.4) 4.9 (2.6) 4.2 (2.8) 0.11
Foot care 5.3 (2.0) 5.0 (2.4) 4.3 (2.2) 0.19
SF-12 scores
Physical component score 33.4 (8.3) 33.5 (5.5) 37.4 (6.1) 0.23
Mental component score 53.7 (8.6) 48.3 (8.4) 42.9 (8.3) ≤0.001
sd = standard deviation.
Table 1 Characteristics of participants by depression status, as determined by the PHQ




Moderate to severe depressive
symptoms (PHQ > 9)
P value
N (%) 29 (48.3) 14 (23.3) 17 (28.3)
Men, n (%) 23 (79.3) 9 (64.3) 13 (76.5) 0.56
Age, years, mean (SD) 65.4 (13.9) 62.4 (13.7) 60.7 (14.4) 0.53
Married or in a relationship, n (%) 18 (62.1) 5 (35.7) 12 (70.6) 0.13
Live alone, n (%) 7 (25.9) 4 (33.3) 1 (9.1) 0.37
High school education or less, n (%) 18 (62.1) 9 (64.3) 10 (58.8) 0.95
Pension as main source of income, n (%) 22 (75.9) 11 (78.6) 12 (70.6) 0.79
Diabetes type 2, n (%) 23 (79.3) 13 (92.9) 12 (70.6) 0.30
Diabetes duration, n (%)
>10 years 18 (62.1) 11 (78.6) 12 (70.6) 0.54
Insulin, n (%) 20 (69) 12 (85.7) 11 (64.7) 0.30
Diabetes complications, n (%)
1 6 (20.7) 4 (28.6) 3 (17.6) 0.96
2 9 (31) 4 (28.6) 6 (35.3)
3+ 14 (48.3) 6 (42.9) 8 (47.1)
Hypertension, n (%) 19 (65.5) 11 (78.6) 12 (70.6) 0.68
Hyperlipidemia, n (%) 17 (58.6) 7 (50) 12 (70.6) 0.49
HbA1C level ≤7.00%, n (%) 6 (26.1) 2 (25) 1 (10) 0.57
Smoking 3 (10.3) 1 (7.1) 4 (23.5) 0.35
Taking antidepressants for depression, n (%) 3 (10.3) 2 (14.3) 12 (70.6) ≤0.0001
Texas Wound Classification, n (%)
Superficial wound 22 (75.9) 11 (84.6) 14 (82.4) 0.42
Infected 7 (24.1) 1 (8.3) 3 (17.6) 0.63
Neuroischaemic 27 (93.1) 13 (92.9) 15 (88.2) 0.69
Ulcer duration >6 months, n (%) 25 (86.2) 9 (64.3) 14 (82.4) 0.23
Due to missing data for A1C: no depression n = 23 and depression n = 18.
Complications: retinopathy, renal impairment, stroke, heart disease, peripheral arterial disease, peripheral neuropathy.
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Table 3 Depression symptoms on the PHQ in previously









(N = 21) (N = 17)
N (%) N (%)
No depressive symptoms (PHQ ≤ 4) 7 (33.3) 0
Mild depressive symptoms (PHQ 5–9) 2 (9.5) 12 (70.6)
Moderate to severe depressive
symptoms (PHQ > 9)
12 (57.1) 5 (29.4)
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primary ulcer status. Due to the number of categories
for comparison and the resulting small number of par-
ticipants in the cells the categories were collapsed into
two categories, comparing participants with a PHQ
score <5 (no depressive symptoms) to those with a PHQ
score >4 (inclusive of mild, moderate and severe depres-
sive symptoms). Data was missing for six participants,
three were lost to follow up and three had died. There
were no significant differences between the two groups.
The three participants who were deceased at the time of
follow-up all had PHQ scores >4. Of the three who had
amputations in this group, two were toe amputations
and another a below knee amputation. There were two
toe amputations in the group with PHQ score <5 and no
deaths were recorded in this group.
Discussion
The present study examined the prevalence of depressive
symptoms including previously unrecognized symptoms,
diabetes self-management, quality of life and ulcer status
at six months follow-up in people with diabetes and foot
ulceration attending outpatient podiatry clinics. There
are a number of important findings from the study.
Firstly, there was a high prevalence of depressive symp-
toms with around half of the participants reporting PHQ
scores > 4. Similar findings have been reported in a num-







Primary wound status N (%) N (%)
Healed 13 (50) 16 (57.1) 0.93
Diminished in size 6 (23.1) 5 (17.9)
Increased in size 3 (11.5) 3 (10.7)
No change in size 2 (7.7) 1 (3.6)
Amputation 2 (7.7) 3 (10.7)
New ulceration at a different site, n (%) 8 (33.3) 6 (24) 0.47to measure depression found around a third of partici-
pants had clinically significant minor or major depres-
sion [9]. The second study using the Beck Depression
Inventory found moderate depression in 64% of partici-
pants and severe depression in 10% [18]. These preva-
lence’s are generally higher than the prevalence of
depression reported in people with diabetes without foot
ulcers, which ranges from 11% using standardized diag-
nostic interviews to 31% when assessed by self-report
[19]. Higher prevalence’s in participants with foot ulcers
may be explained in part by the increased burden associ-
ated with having a foot ulcer.
Secondly, this study also found an association between de-
pressive symptoms and poorer diabetes self-management.
Gonzalez and colleagues report findings consistent with
this in addition to an association with poorer medica-
tion adherence [20]. While there was no association
found in this study with physical functioning and de-
pressive symptoms the scores on the SF-12 for this
component were generally low (overall mean 34.6, SE 0.9)
compared with age and sex matched data for the
Australian population with diabetes (mean 44.0, SE
1.0) [21]. Goodridge and colleagues have previously
reported similar low scores on the SF-12 for physical
functioning when comparing groups of participants
with healed and unhealed ulcers [22]. Caution should
be applied when interpreting the result from this study
due to the generic nature of the SF-12 measure. The use
of a foot-ulcer specific measure such as the NeuroQoL
may have been better at detecting an association between
the presence of foot ulcers and poorer quality of life.
Validation studies comparing the NeuroQoL with the SF-
12 have shown the NeuroQoL to be a superior instrument
in this regard [17]. In the absence of having used a
disease-specific measure in this study it is difficult to know
with confidence the results from the SF-12 are directly re-
lated to the presence of a foot ulcer when there are poten-
tially other conditions that might also explain the low
physical functioning scores. Decreasing mental wellbeing
(MCS) on the SF-12 was associated with increasing de-
pressive symptoms. This is not so surprising as the MCS
and PHQ both measure constructs of mental well-being.
They are, however different measures. The MCS is a more
general assessment of emotional problems and their im-
pact on work, daily activities and social activities over the
last 4 weeks whereas the PHQ-9 is a more focused meas-
ure of depressive symptoms. The MCS provides some
additional information over and above that measured by
the PHQ regarding the influence of poor mental health on
other domains of life.
Thirdly, this study found no association between de-
pression and ulcer outcomes at six-months follow-up.
There have been very few studies including this one to
date and the results have been inconsistent. Monami
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impaired ulcer healing at six months and recurrence of
ulcers at twelve months and greater depressive symp-
toms. In contrast, a study by Winkley and colleagues [2]
using a larger cohort and a longer follow-up period
found no association between greater depressive symp-
toms and ulcer healing at eighteen months. This study
by Winkley et al. did however report a significant associ-
ation with increased mortality at eighteen months and in
a subsequent five year follow-up of the cohort [23].
While this is consistent with an increase in mortality
found in our study in those with depressive symptoms
versus those without we did not test this statistically due
to the small sample size. We also found no differences
in amputations between the groups in association with
depression. This is in contrast to a previous study by
Williams and colleagues [24] who found an increase of
33% in amputation risk associated with diagnosed de-
pression over a four year period. The large sample size
of over 600,000 participants in this study and extended
follow-up are probably explanations for the discrepan-
cies in findings.
Another important finding from this study was that 28%
of participants had previously unrecognized depression,
which is also consistent with previous studies [12,25,26].
Unrecognized depression in this study was associated with
a higher proportion of participants having mild depres-
sion. A possible and perhaps obvious explanation for this
is that moderate to severe symptoms of depression are
more apparent and therefore easier to diagnose. These pa-
tients may also be more likely to seek treatment. Identifi-
cation of depression in people with diabetes can be
problematic as some of the symptoms of depression are
also symptomatic of a diagnosis of diabetes and may ex-
plain why it goes unrecognized.
The large majority of participants with previously rec-
ognized depression were being treated with antidepres-
sants and most of them for more than two years.
Maintenance pharmacotherapy is sometimes a recom-
mended treatment option in cases where there are high
rates of relapse. Certainly depression in people with dia-
betes does tend to be more chronic and long lasting
[27]. In this study we have shown, however, that such
maintenance pharmacotherapy was not effective in treat-
ing their depression as many of these people continued
to experience moderate to severe depression as indicated
by their scores on the PHQ. A concern of long-term
treatment with some antidepressants particularly with
regard to people with diabetes is the side effect of weight
gain [28] and potential to delay wound healing [29].
An important question that this study raises is whether
or not patients who had been on long-term antidepres-
sants had received any other form of psychotherapeutic
interventions for their depression. The benefits ofpsychotherapeutic interventions including cognitive be-
havioral therapy are well documented [30]. This meta-
analysis of fourteen randomized trials found the most
significant effects on depression and glycemic control in
people with diabetes was associated with psychothera-
peutic interventions when compared with pharmacological
interventions only or a combination of both pharmaco-
logical and psychotherapeutic interventions. Major policy
changes introduced in Australia in 2006 to increase access
to mental health services have shown that around 46% of
people with mental health problems accessed specialist ser-
vices in 2009–2010 a significant improvement from 37% in
2006. However, what is not known is whether people
accessing these services received evidence-based therapies
and what their outcomes were [31]. This in addition to
other studies acknowledging a treatment gap regarding
evidence-based treatment of mental health problems leads
one to speculate that the patients in this study may not
have received these other forms of non-pharmacological
interventions [32-35].
For a number of years international diabetes guidelines
have been recommending routine screening of patients
with diabetes for depression and diabetes-related distress
[36,37]. Guidelines recently released in Australia by the
Royal Australasian College of General Practitioners also
acknowledge the need for addressing the psychological
well-being of these patients [38]. This rationale is based
on substantial evidence of an increased prevalence of
emotional problems in people with diabetes [7], its asso-
ciation with adverse outcomes including diabetes-related
complications [23,39] and the availability of effective
treatments [30]. This equates to a strong argument that
such problems should be addressed and that these indi-
viduals need to be identified. Whether the implementa-
tion of routine screening in secondary care is the most
efficient and cost-effective way of doing this remains
controversial. A recent study [40] evaluating routine
screening in an outpatient diabetes clinic found up to
30% of patients were missed by screening and only a
small number of patients who screened positive were
happy to be referred on for further treatment. Those
missed by screening were more likely to be smokers and
younger, have high HbA1c, show lower adherence to
diabetes care in general, and therefore also be more
likely to be at a greater risk of having depression [41]. A
problem with the screening debate is a lack of empirical
evidence in terms of rigorous randomized controlled
trials around screening. Issues that need to be addressed
include feasibility and cost-effectiveness, where screening
should take place (primary or secondary care), the best
way to identify ‘high-risk patients’ what resources are re-
quired and what constitutes a successful outcome for the
patients (clinical endpoints, quality of life, reductions
or delay in complications). What is not controversial is a
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sues around psychological distress and depression in
these patients deserve attention in the clinical setting.
Limitations of the study include the small sample size
and that housebound and community clinic patients
with ulcers would not have been identified. This limits
the generalization of the study results to some degree
and the statistical analysis. An additional limitation was
the missing data for HbA1C. It was not in the protocol
to measure this at the time of consent and was reliant
on existing documentation in the medical records. It
raises questions about the representativeness of the data.
Also there are inherent limitations with self-report ques-
tionnaires such as under or over reporting.
Conclusion
In conclusion this study found a high prevalence of de-
pression as determined using the PHQ in people with dia-
betes and foot ulcers. Most with severe depression were
being treated with antidepressants, however the prolonged
use of antidepressants appears to be ineffective in the ma-
jority of cases. There was also a high prevalence of partici-
pants with mild to moderate depressive symptoms that
were not previously identified. This is concerning given
the evidence from other research in this area of an associ-
ation of mild depression in people with diabetes and foot
ulcers with increased mortality [23]. It has been recog-
nised that mild depression in people with diabetes is a sig-
nificant predictor of severe depression at two years follow-
up [42]. With the increasing incidence of diabetes globally,
identification of previously unrecognized depression (mild
and moderate to severe) in people with diabetes either be-
fore the onset of complications or those with existing
complications is important as it provides the opportunity
for early intervention. From a public health perspective
the provision of evidence-based therapies for those with
depression and foot ulceration should form part of the
holistic management of this group with complex medical
and psychosocial needs.
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